SAFIRA stands for Safer Injection Regional Anaesthesia, a medical device developed by Medovate, a company based in Cambridge in the United Kingdom, along with the Queen Elizabeth Hospital, Kings Lynn Foundation Trust.
The device contains a safety feature that helps prevent anaesthetic being injected at unsafe pressures, aiming to reduce the risk of significant or peripheral nerve damage.
The device makes the regional anaesthesia process a one-person procedure by a single anaesthetist.
You can find out more information about SAFIRA by visiting Medovate's website.
